Sort by
Refine Your Search
-
Listed
-
Country
-
Program
-
Field
-
transporters are LAT1, SNAT2 and PAT1 as these have all been implicated in cancer. The project will do this via computational modeling and design using AlphaFold3.0 and available protein structures and ligand
-
BUG-ID is a Marie Sklodowska-Curie Doctoral Network project, funded by the European Commission, Horizon Europe Program. Commencing its activities in January 2026, the Network will provide PhD
-
foundations, quantum information theory, and quantum technologies. For additional information, please visit: https://dakic.univie.ac.at/ . Your future tasks: You will actively participate in research, teaching
-
-year contract starting September/October 2026 https://www.eu4greenfielddata.eu/ APPLICATIONS OPEN ON Juanary 5th 2026 Are you an aspiring researcher ready to drive the digital and green transition in
-
Smet ( https://desmetlab.sites.vib.be ) and F. Van Breusegem ( https://vanbreusegemlab.sites.vib.be ) have expertise in abiotic stress signaling and in advanced molecular profiling, including mass
-
, computer science, medicine, pharmacology, and physics. ISAS is a member of the Leibniz Association and is publicly funded by the Federal Republic of Germany and its federal states. As part of the DFG-funded
-
are proud to work together in a truly integrating manner. Our partners, e.g. University of Hamburg, the Max Planck Institute for Meteorology or the German Climate Computing Centre are also hiring. All jobs
-
You apply through our recruitment system on 30 March 2026, at the latest (https://umu.varbi.com/en/what:job/jobID:905098/ ). The application, written in English, should include: A short (max 2 pages
-
actively to our weekly group meetings and some administrative duties - Complete the training programme for PhDs at the University of Vienna - Disseminate and present your work and represent the group through
-
of the 14 doctoral candidates recruited from 9 European countries. STEM-CORE, supported by the Marie Skłodowska-Curie Actions (MSCA) programme, aims to explore strategies to develop stem cell therapies and